← Back to catalogue

PMS2 IHC pharmDx (Dako Omnis)

FDA UDI

Class III (US FDA UDI)

by Agilent Technologies Inc.

Identity

Trade Name
PMS2 IHC pharmDx (Dako Omnis) FDA UDI
Generic Name
Postmeiotic segregation increased 2 (PMS2) IVD, antibody FDA UDI
Device Name
PMS2 IHC pharmDx (Dako Omnis) FDA UDI
Model / Reference
GE087 FDA UDI
Description
PMS2 IHC pharmDx (Dako Omnis) FDA UDI

Identifiers

Primary DI / UDI-DI
05700575005244 FDA UDI
PMA Number
P250004 FDA UDI
FDA Product Code
QNH FDA UDI
GMDN Term
Postmeiotic segregation increased 2 (PMS2) IVD, antibody FDA UDI

Classification

Device Class
Class III FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 12 Milliliter FDA UDI

Category: Postmeiotic segregation increased 2 (PMS2) IVD, antibody

PMS2 IHC pharmDx (Dako Omnis) by Agilent Technologies Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Postmeiotic segregation increased 2 (PMS2) IVD, antibody.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 1cd3ee8c-1bff-49d9-823f-90eefbdf3a60 37 fields · synced May 30, 2026